NL-OMON21490招募中不适用
Dimethyl fumarate, advanced neuroimaging and cognition in MS
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- Biogen
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1) ability to understand purpose of the study and provide informed consent
- •2) 18-65 years old
- •3) need to meet safety criteria to undergo MRI-scan
- •4) sufficient visual acuity and motor skills to perfom fMRI task
- •5) patients with RRMS
- •6) if using other drugs influencing CNS, they need to be stable on this medication at least for 6 months.
排除标准
- •1) unable/unwilling to provide informed consent
- •2) presence/history psychiatric or neurological disease (other than MS for patient group) that may affect outcome measures
- •3) contra-indication for MRI
- •4) history/presence alcohol/drug abuse
- •5) participation in other studies using cognitive or physical training programs to avoid noise.
- •For patient groups specifically:
- •6) PPMS or SPMS
- •7) relapse and steroid treatment 4 weeks < examination
研究者
相似试验
撤回
2 期
Dimethyl Fumarate for the Treatment of Intracerebral HemorrhageIntracerebral HemorrhageNCT04890379Xuanwu Hospital, Beijing
招募中
1 期
Effect of dimethyl fumarate administered to patients with adrenomyeloneuropathy: a multicenter, placebo controlled, phase IIb/III trialAdrenomyeloneuropathyCTIS2023-506795-27-00Fundacio Institut D Investigacio Biomedica De Bellvitge IDIBE40
已完成
不适用
Tecfidera Diffusion Tensor ImagingMultiple Sclerosis, Dimethyl Fumarate, Diffusion Tensor Imaging Magnetic Resonance ImagingNCT02686684University at Buffalo115
已完成
不适用
Effects of Dimethyl Fumarate on Cognitive Performance and Brain Abnormalities in Multiple Sclerosis.Multiple SclerosisNCT05811949IRCCS Centro Neurolesi Bonino Pulejo52
已完成
Unknown
[18F]-flutemetamol amyloid imaging along the continuum from normal cognitive status to Alzheimer's disease dementia.JPRN-jRCT1091220124Shizuo Hatashita120